The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition

Completed · Not applicable · Has a placebo group

Conditions studied: Mild Cognitive Impairment, NAD

In brief

The purpose of this study is to determine the effects of Niagen (nicotinamide riboside, vitamin B3), on NAD levels, brain function including cognition and blood flow in people diagnosed with mild cognitive impairment (MCI).

Key facts

Study ID
NCT02942888
Run by
The University of Texas Health Science Center at San Antonio
People needed
46
Starts
2017-11-30
Expected to finish
2021-08-16
Last updated by the study team
2021-09-02

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.